Hyperbaric oxygen therapy as an adjuvant to source... (2017 study) Skip to main content
Retrospective Study Undersea & hyperbaric medicine : journal of the Undersea and Hyperbaric Medical Society, Inc 2017

Hyperbaric oxygen therapy as an adjuvant to source control in necrotizing soft tissue infections.

Ferreira APP, Vide SS, Fernandes TDF, Coelho PMBS, Camacho ÓF, Undersea & hyperbaric medicine : journal of the Undersea and Hyperbaric Medical Society, Inc, 2017

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers in Portugal looked back at the records of 58 people with a rare, severe soft tissue infection who were treated with hyperbaric oxygen (HBO2) therapy, to see how surgery, HBO2 and negative pressure wound therapy related to the time it took to get the infection under control.

What They Found

In this retrospective study of 58 patients with necrotizing soft tissue infections treated with HBO2, a statistical model linked more frequent and earlier HBO2 sessions to a shorter time until source control (control of the infection's origin). Overall mortality was 13.8 percent, and the mean time until source control was 10.4 days. Patients averaged 0.62 surgical interventions and 1.06 HBO2 sessions per day. After adjusting for other factors, doubling the number of HBO2 sessions per day was associated with source control about five days sooner. Each day HBO2 was delayed was associated with source control one day later.

What This Means for Canadian Patients

For people with necrotizing soft tissue infections, this study suggests that how early and how often HBO2 sessions were given was linked to how quickly the infection was controlled in this group. It was not a trial that assigned treatments, so it cannot show that HBO2 caused the faster control. The abstract also reports that about 1 in 7 patients died, which shows how serious these infections are. Treatment decisions belong with the surgical and hyperbaric medicine team.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

This was a retrospective study from a single hyperbaric unit with 58 patients and no comparison group of patients who did not receive HBO2, so the links it found may not reflect cause and effect.

This plain-language summary was generated with AI assistance from the study's abstract; it has not been individually reviewed by a clinician. Always consult the source study and a qualified healthcare professional. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Retrospective Study
Category Wound Care
Source Pubmed
PubMed ID 29281190
Year Published 2017
Journal Undersea & hyperbaric medicine : journal of the Undersea and Hyperbaric Medical Society, Inc
MeSH Terms Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Combined Modality Therapy; Debridement; Female; Humans; Hyperbaric Oxygenation; Male; Middle Aged; Necrosis; Portugal; Retrospective Studies

Cite This Study

Share

This study relates to Problem Wounds. Read the full clinical overview, the evidence base, and Canadian treatment access for this condition.

Find a Canadian Clinic Treating Wound Care

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last updated: April 1, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology